학술논문
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Document Type
Article
Author
Loibl, S. ; Untch, M.; Burchardi, N.; Huober, J.; Sinn, B.V.; Blohmer, J.-U.; Grischke, E.-M.; Furlanetto, J.; Tesch, H.; Hanusch, C.; Engels, K.; Rezai, M.; Jackisch, C.; Schmitt, W.D.; von Minckwitz, G.; Thomalla, J.; Kümmel, S.; Rautenberg, B.; Fasching, P.A.; Weber, K.; Rhiem, K.; Denkert, C.; Schneeweiss, A.
Source
In Annals of Oncology August 2019 30(8):1279-1288
Subject
Language
ISSN
0923-7534